Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Document series

Analytical and methodological standards

18 standards covering the determination of identity, purity, content and quality, and the documentation that makes a determination interpretable.

A standard states what a determination establishes, what performance the procedure must demonstrate, and what the result does not support. It states performance rather than prescribing a fixed procedure, so that the series does not freeze against methodological improvement.

Several standards in this series describe attributes the Institute has found to be measured rarely or never in the research-supply channel. A standard for an attribute nobody measures is published because the requirement is a property of the measurement and not of current practice, a position settled through public consultation.

Standards

18 documents
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.